HTB Chemical Compound Collections (Full List)
Browse the complete list of chemical compound collections available at HTB, ranging from broad diversity libraries to focused sets tailored for specific pathways, targets, and disease areas.
12 New Libraries Arrived at the End of 2025
| Library name |
Vendor |
Total compounds |
View compound list |
Description |
|
Enamine |
100 160 |
|
Broad diversity set designed for early hit finding with strong medicinal chemistry tractability. |
|
Enamine |
10 240 |
|
Next-generation diversity collection representing the latest high-quality chemotypes. |
|
Life Chemicals |
3 200 |
|
Structurally diverse kinase-inhibitor-like molecules suitable for exploratory screening. |
|
MedChemExpress |
3 092 |
|
Collection of known kinase inhibitors and modulators covering major signaling pathways. |
|
MedChemExpress |
752 |
|
Compounds targeting key nodes in lipid metabolic pathways. |
|
MedChemExpress |
2 684 |
|
Molecules modulating apoptotic pathways and cell-death regulators. |
|
MedChemExpress |
2 981 |
|
Compounds with anti-neurodeCompounds with activity against neurodegeneration-associated targets and pathways. |
|
TargetMol |
2 271 |
|
A collection of GPCR-active small molecules selected for structural diversity, specificity, and cell permeability. |
|
TargetMol |
950 |
|
Molecules acting on mitochondrial pathways including ETC, OXPHOS, Ca²⁺ handling, and redox regulation. |
|
TargetMol |
1 268 |
|
Molecules targeting tumor-associated metabolic pathways — including glycolysis, glutaminolysis, and key regulatory enzymes involved in cancer metabolism |
|
TargetMol |
1 260 |
|
Compounds modulating epigenetic pathways and chromatin regulation. |
|
TargetMol |
1 106 |
|
Includes various antibiotics and antibacterial bioactive compounds with unique chemical scaffolds. |
Large Compound Collections Are Ideal For Finding New Drugs
Library
|
№ compounds
|
Year Acquired by HTB |
Content description
|
| Specs Consortium Collection |
30 000 |
2012 |
Combinatorial chemistry collection |
| ChemDiv Peptidomimetic library |
15 614 |
2012 |
Peptide mimicking small compounds |
|
~100 000 |
2020 |
European Chemical Biology Library (ECBL) commercial diversity compound collection |
Focused Libraries Better Suit for Biological Profiling and Drug Repositioning
Library
|
№ compounds
|
Year Acquired by HTB |
Description
|
| FIMM oncology collections |
>1 000 |
2010- |
Oncology set of approved and emerging investigational oncology drugs, compounds available also for proof-of-principle experiments |
| FIMM metabolic library |
183 |
2024 |
Targeting major metabolic pathways (mitochondria, energy, lipids, proteins and nucleotides) |
| Comprehensive anti-Cancer small-Compound Library (C3L) |
620 |
2022 |
Oncology set of approved and emerging investigational oncology drugs |
| Prestwick Chemical Library |
1 520 |
2024 |
FDA-approved & EMA-approved drugs |
| FDA-approved drugs ENZO |
640 |
2009 |
FDA-approved drugs |
| SPECTRUM MicroSource |
2 000 |
2009 |
The Drug Components (50%); The Natural Products (30%); Other Bioactive Components (20%) |
Smaller Oncology Collections for Clinical Applications
Library
|
№ compounds
|
Year Acquired by HTB |
Description
|
| FO |
528 |
2011- |
FIMM oncology collection, a comprehensive collection of approved and emerging investigational oncology drugs in 5 concentrations each (FO6B is the latest version) |
| FM |
142 |
2014- |
FIMM myeloma-specific collection (5 conc.) |
| FA |
151 |
2015- |
FIMM AML-specific panel (5 conc.) |
| QA |
40 |
2019- |
AML-specific drugs in 7 concentrations for HT flow cytometry |